DURHAM, N.C., February 20, 2017 — Premier Research is a presenting sponsor of this year’s Outsourcing in Clinical Trials West Coast conference in Burlingame, California, and two company executives are speaking at the event.
Dr. Colin Hayward, Chief Medical Officer, will speak on moving oncology molecules to proof of concept on Wednesday, February 22, at 9 a.m. Hayward will discuss study design options, accelerating regulatory approval, patient selection, biomarker planning, and development of immune therapeutics.
On the same morning, Dr. Krista Armstrong, Vice President of Strategic Development, will participate in a panel discussion on strategic outsourcing models and their impact on forging effective partnerships. Dr. Armstrong’s panel begins at 9:30 a.m.
OCT West Coast, February 22-23, is the region’s flagship clinical trials outsourcing event. It will bring together more than 700 clinical professionals to discuss outsourcing strategies and overcoming challenges in clinical operations.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.